Obesity Management: Clinical Review and Update of the Pharmacologic Treatment Options.
作者： Bradley Kramer , Quang T Nguyen , Jennifer Lee , Megan E McGarvey , Keith Reisinger-Kindle
DOI:
关键词:
摘要: The toolbox of medications available for medical weight management is more robust than ever and includes a wide variety mechanisms actions options patients.
touro.edu参考文章(27)
Jarl S Torgerson, Krister Arlinger, Marcus Käppi, Lars Sjöström, Principles for Enhanced Recruitment of Subjects in a Large Clinical Trial Controlled Clinical Trials. ,vol. 22, pp. 515- 525 ,(2001) , 10.1016/S0197-2456(01)00165-9
M L Drent, E A van der Veen, Lipase inhibition: a novel concept in the treatment of obesity International Journal of Obesity. ,vol. 17, pp. 241- 244 ,(1993)
Wilding JP Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, SCALE Obesity and Prediabetes NN8022-1839 Study Group., None, A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management The New England Journal of Medicine. ,vol. 373, pp. 11- 22 ,(2015) , 10.1056/NEJMOA1411892
D. Sall, J. Wang, M. Rashkin, M. Welch, C. Droege, D. Schauer, Orlistat‐induced fulminant hepatic failure Clinical obesity. ,vol. 4, pp. 342- 347 ,(2014) , 10.1111/COB.12075
Raymond A Plodkowski, Quang Nguyen, Umasankari Sundaram, Loida Nguyen, Diane L Chau, Sachiko St Jeor, Bupropion and naltrexone: a review of their use individually and in combination for the treatment of obesity. Expert Opinion on Pharmacotherapy. ,vol. 10, pp. 1069- 1081 ,(2009) , 10.1517/14656560902775750
Kishore Gadde, Shin, Clinical utility of phentermine/topiramate (Qsymia™) combination for the treatment of obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. ,vol. 6, pp. 131- 139 ,(2013) , 10.2147/DMSO.S43403
Patrick M. O'Neil, Steven R. Smith, Neil J. Weissman, Meredith C. Fidler, Matilde Sanchez, Jinkun Zhang, Brian Raether, Christen M. Anderson, William R. Shanahan, Randomized Placebo‐Controlled Clinical Trial of Lorcaserin for Weight Loss in Type 2 Diabetes Mellitus: The BLOOM‐DM Study Obesity. ,vol. 20, pp. 1426- 1436 ,(2012) , 10.1038/OBY.2012.66
J. Hauptman, Orlistat in the Long-term Treatment of Obesity in Primary Care Settings Archives of Family Medicine. ,vol. 9, pp. 160- 167 ,(2000) , 10.1001/ARCHFAMI.9.2.160
T A Wadden, , P Hollander, S Klein, K Niswender, V Woo, P M Hale, L Aronne, Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study International Journal of Obesity. ,vol. 37, pp. 1443- 1451 ,(2013) , 10.1038/IJO.2013.120
P. Hollander, A. K. Gupta, R. Plodkowski, F. Greenway, H. Bays, C. Burns, P. Klassen, K. Fujioka, , Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. ,vol. 36, pp. 4022- 4029 ,(2013) , 10.2337/DC13-0234